AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4/A] Alignment Healthcare, Inc. Amended Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4/A
Rhea-AI Filing Summary

Alignment Healthcare (ALHC) â€� Amended Form 4 (Form 4/A)

CEO and Director John E. Kao corrected a prior Form 4 to reflect the accurate number of shares withheld for tax obligations triggered by the vesting of service-based restricted stock units (RSUs). On 08-Mar-2024, 35,801 common shares were automatically withheld at an implied price of $5.39 per share under Transaction Code â€œFâ€� (tax-withholding, non-discretionary). Following the adjustment, Kao’s direct beneficial ownership stands at 2,310,972 shares.

The filing explicitly states that no investment decision was made; the shares were removed solely to satisfy federal tax liabilities. The amendment rectifies an “administrative errorâ€� in the original Form 4 filed on 12-Mar-2024.

  • Nature of transaction: Non-open-market, tax-withholding event.
  • Impact on insider’s stake: Less than 2% reduction in Kao’s holdings; he retains a substantial ownership position.
  • Market significance: Typically viewed as neutral because it is mandatory and does not signal sentiment about ALHC’s prospects.

Alignment Healthcare (ALHC) � Modifica al Modulo 4 (Modulo 4/A)

Il CEO e Direttore John E. Kao ha corretto un precedente Modulo 4 per riflettere il numero esatto di azioni trattenute per obblighi fiscali derivanti dal consolidamento di unità azionarie vincolate basate su servizio (RSU). In data 08-mar-2024, sono state automaticamente trattenute 35.801 azioni ordinarie al prezzo implicito di $5,39 per azione, secondo il Codice di Transazione “F� (ritenuta fiscale, non discrezionale). Dopo la rettifica, la proprietà diretta di Kao ammonta a 2.310.972 azioni.

Il documento specifica chiaramente che non è stata presa alcuna decisione di investimento; le azioni sono state rimosse esclusivamente per adempiere agli obblighi fiscali federali. La modifica corregge un “errore amministrativo� nel Modulo 4 originale presentato il 12-mar-2024.

  • Natura della transazione: Evento di ritenuta fiscale non di mercato aperto.
  • Impatto sulla partecipazione dell’insider: Riduzione inferiore al 2% delle azioni di Kao; mantiene una posizione azionaria significativa.
  • Significato per il mercato: Generalmente considerato neutro poiché obbligatorio e non indicativo del sentimento verso le prospettive di ALHC.

Alignment Healthcare (ALHC) � Modificación del Formulario 4 (Formulario 4/A)

El CEO y Director John E. Kao corrigió un Formulario 4 previo para reflejar el número exacto de acciones retenidas por obligaciones fiscales derivadas de la consolidación de unidades restringidas basadas en servicio (RSU). El 08-mar-2024, se retuvieron automáticamente 35,801 acciones comunes a un precio implícito de $5.39 por acción bajo el Código de Transacción “F� (retención fiscal, no discrecional). Tras el ajuste, la propiedad directa de Kao es de 2,310,972 acciones.

La presentación indica explícitamente que no se tomó ninguna decisión de inversión; las acciones fueron retiradas únicamente para cumplir con obligaciones fiscales federales. La enmienda corrige un “error administrativo� en el Formulario 4 original presentado el 12-mar-2024.

  • Naturaleza de la transacción: Evento de retención fiscal fuera del mercado abierto.
  • Impacto en la participación del insider: Reducción inferior al 2% en las acciones de Kao; mantiene una posición accionaria significativa.
  • Significado para el mercado: Generalmente considerado neutral porque es obligatorio y no indica sentimiento sobre las perspectivas de ALHC.

Alignment Healthcare (ALHC) â€� 수정ë� ì–‘ì‹ 4 (ì–‘ì‹ 4/A)

CEO ê²� ì´ì‚¬ì� John E. KaoëŠ� 서비ìŠ� 기반 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ì� 베스팅으ë¡� ë°œìƒí•� 세금 ì˜ë¬´ë¥� 충족하기 위해 ì›ëž˜ 제출í•� ì–‘ì‹ 4ì—서 정확í•� ì£¼ì‹ ìˆ˜ë¥¼ ë°˜ì˜í•˜ë„ë¡� 수정했습니다. 2024ë…� 3ì›� 8ì�, 35,801ì£�ì� 보통주가 주당 $5.39ì� 내재 가격으ë¡� 거래 코드 “Fâ€�(세금 ì›ì²œì§•수, 비재량ì )ì—� ë”°ë¼ ìžë™ìœ¼ë¡œ ì›ì²œì§•수ë˜ì—ˆìŠµë‹ˆë‹�. ì¡°ì • í›� Kaoì� ì§ì ‘ 소유 ì£¼ì‹ ìˆ˜ëŠ” 2,310,972ì£�입니ë‹�.

신고섵ӗµç� íˆ¬ìž ê²°ì •ì€ ì „í˜€ ì´ë£¨ì–´ì§€ì§€ 않았ë‹�ê³� 명시ë˜ì–´ 있으ë©�, 주ì‹ì€ ì—°ë°© 세금 ë‚©ë¶€ë¥� 위해서만 ì°¨ê°ë˜ì—ˆìŠµë‹ˆë‹�. ì´ë²ˆ ìˆ˜ì •ì€ 2024ë…� 3ì›� 12ì¼ì— 제출ë� ì›ë³¸ ì–‘ì‹ 4ì� â€œí–‰ì •ì  ì˜¤ë¥˜â€ë¥¼ ë°”ë¡œìž¡ì€ ê²ƒìž…ë‹ˆë‹¤.

  • 거래 성격: 비공ê°� 시장 세금 ì›ì²œì§•수 ì´ë²¤íŠ�.
  • ë‚´ë¶€ìž� ì§€ë¶„ì— ë¯¸ì¹˜ëŠ� ì˜í–¥: Kaoì� 보유 ì§€ë¶„ì´ 2% 미만으로 ê°ì†Œí–ˆìœ¼ë©�, 여전íž� ìƒë‹¹í•� ì†Œìœ ê¶Œì„ ìœ ì§€í•˜ê³  있습니다.
  • 시장ì—� 미치ëŠ� ì˜ë¯¸: ì˜ë¬´ì ì´ë©� ALHCì� ì „ë§ì—� 대í•� 신호가 아니므ë¡� ì¼ë°˜ì ìœ¼ë¡� 중립ì ìœ¼ë¡� 간주ë©ë‹ˆë‹�.

Alignment Healthcare (ALHC) � Formulaire 4 modifié (Formulaire 4/A)

Le PDG et administrateur John E. Kao a corrigé un formulaire 4 antérieur pour refléter le nombre exact d’actions retenues pour les obligations fiscales déclenchées par l’acquisition de unités d’actions restreintes basées sur le service (RSU). Le 08 mars 2024, 35 801 actions ordinaires ont été automatiquement retenues à un prix implicite de 5,39 $ par action sous le code de transaction « F » (retenue fiscale, non discrétionnaire). Après cet ajustement, la propriété directe de Kao s’élève à 2 310 972 actions.

Le dépôt précise explicitement qu�aucune décision d’investissement n’a été prise ; les actions ont été retirées uniquement pour satisfaire aux obligations fiscales fédérales. L’amendement corrige une « erreur administrative » dans le formulaire 4 original déposé le 12 mars 2024.

  • Nature de la transaction : Opération de retenue fiscale hors marché ouvert.
  • Impact sur la participation de l’initié : Réduction de moins de 2 % des avoirs de Kao ; il conserve une position de propriété importante.
  • Signification pour le marché : Généralement considérée comme neutre car obligatoire et ne reflète pas le sentiment sur les perspectives d’ALHC.

Alignment Healthcare (ALHC) � Geändertes Formular 4 (Formular 4/A)

CEO und Direktor John E. Kao korrigierte ein zuvor eingereichtes Formular 4, um die korrekte Anzahl der für Steuerverpflichtungen einbehaltenen Aktien aufgrund der Vesting von dienstbasierten Restricted Stock Units (RSUs) widerzuspiegeln. Am 08. März 2024 wurden 35.801 Stammaktien automatisch zu einem impliziten Preis von $5,39 pro Aktie gemäß Transaktionscode „F� (steuerliche Einbehaltung, nicht diskretionär) einbehalten. Nach der Anpassung beträgt Kaos direkte wirtschaftliche Beteiligung 2.310.972 Aktien.

Die Einreichung stellt ausdrücklich klar, dass keine Investitionsentscheidung getroffen wurde; die Aktien wurden ausschließlich zur Erfüllung der Bundessteuerverpflichtungen entnommen. Die Änderung korrigiert einen „administrativen Fehler� im ursprünglichen Formular 4, das am 12. März 2024 eingereicht wurde.

  • Art der Transaktion: Nicht am offenen Markt, steuerliche Einbehaltung.
  • Auswirkung auf Insider-Beteiligung: Weniger als 2 % Reduktion von Kaos Anteilen; er behält eine bedeutende Eigentumsposition.
  • Bedeutung für den Markt: Wird typischerweise als neutral angesehen, da es verpflichtend ist und keine Aussage über die Aussichten von ALHC trifft.
Positive
  • No discretionary sale; shares withheld solely for taxes, avoiding negative signaling.
  • Accurate disclosure via timely amendment demonstrates compliance diligence.
Negative
  • Reduction of 35,801 shares modestly lowers CEO’s direct stake.
  • Prior administrative error indicates a minor lapse in reporting controls.

Insights

TL;DR: Routine tax-withholding; neutral to valuation.

The amended Form 4 corrects share count, showing 35,801 shares withheld for taxes on RSU vesting. Such "F" code transactions are non-discretionary and do not reflect the CEO’s outlook. After the adjustment, Kao still controls roughly 2.3 million shares, a sign of continued alignment with shareholders. Equity value impact is negligible; float reduction is immaterial and cash proceeds remain with the company for tax remittance rather than the insider. I view the filing as informational and neutral.

TL;DR: Amendment improves disclosure accuracy; minor governance positive.

Correcting the prior filing underscores ALHC’s attention to compliance under Section 16(a). While the share adjustment is small, prompt remediation reduces regulatory risk and supports transparency. Because the transaction is automatic and non-market, it neither raises red flags nor materially alters insider ownership structures. Governance impact is mildly favorable, but overall market impact remains neutral.

Alignment Healthcare (ALHC) � Modifica al Modulo 4 (Modulo 4/A)

Il CEO e Direttore John E. Kao ha corretto un precedente Modulo 4 per riflettere il numero esatto di azioni trattenute per obblighi fiscali derivanti dal consolidamento di unità azionarie vincolate basate su servizio (RSU). In data 08-mar-2024, sono state automaticamente trattenute 35.801 azioni ordinarie al prezzo implicito di $5,39 per azione, secondo il Codice di Transazione “F� (ritenuta fiscale, non discrezionale). Dopo la rettifica, la proprietà diretta di Kao ammonta a 2.310.972 azioni.

Il documento specifica chiaramente che non è stata presa alcuna decisione di investimento; le azioni sono state rimosse esclusivamente per adempiere agli obblighi fiscali federali. La modifica corregge un “errore amministrativo� nel Modulo 4 originale presentato il 12-mar-2024.

  • Natura della transazione: Evento di ritenuta fiscale non di mercato aperto.
  • Impatto sulla partecipazione dell’insider: Riduzione inferiore al 2% delle azioni di Kao; mantiene una posizione azionaria significativa.
  • Significato per il mercato: Generalmente considerato neutro poiché obbligatorio e non indicativo del sentimento verso le prospettive di ALHC.

Alignment Healthcare (ALHC) � Modificación del Formulario 4 (Formulario 4/A)

El CEO y Director John E. Kao corrigió un Formulario 4 previo para reflejar el número exacto de acciones retenidas por obligaciones fiscales derivadas de la consolidación de unidades restringidas basadas en servicio (RSU). El 08-mar-2024, se retuvieron automáticamente 35,801 acciones comunes a un precio implícito de $5.39 por acción bajo el Código de Transacción “F� (retención fiscal, no discrecional). Tras el ajuste, la propiedad directa de Kao es de 2,310,972 acciones.

La presentación indica explícitamente que no se tomó ninguna decisión de inversión; las acciones fueron retiradas únicamente para cumplir con obligaciones fiscales federales. La enmienda corrige un “error administrativo� en el Formulario 4 original presentado el 12-mar-2024.

  • Naturaleza de la transacción: Evento de retención fiscal fuera del mercado abierto.
  • Impacto en la participación del insider: Reducción inferior al 2% en las acciones de Kao; mantiene una posición accionaria significativa.
  • Significado para el mercado: Generalmente considerado neutral porque es obligatorio y no indica sentimiento sobre las perspectivas de ALHC.

Alignment Healthcare (ALHC) â€� 수정ë� ì–‘ì‹ 4 (ì–‘ì‹ 4/A)

CEO ê²� ì´ì‚¬ì� John E. KaoëŠ� 서비ìŠ� 기반 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ì� 베스팅으ë¡� ë°œìƒí•� 세금 ì˜ë¬´ë¥� 충족하기 위해 ì›ëž˜ 제출í•� ì–‘ì‹ 4ì—서 정확í•� ì£¼ì‹ ìˆ˜ë¥¼ ë°˜ì˜í•˜ë„ë¡� 수정했습니다. 2024ë…� 3ì›� 8ì�, 35,801ì£�ì� 보통주가 주당 $5.39ì� 내재 가격으ë¡� 거래 코드 “Fâ€�(세금 ì›ì²œì§•수, 비재량ì )ì—� ë”°ë¼ ìžë™ìœ¼ë¡œ ì›ì²œì§•수ë˜ì—ˆìŠµë‹ˆë‹�. ì¡°ì • í›� Kaoì� ì§ì ‘ 소유 ì£¼ì‹ ìˆ˜ëŠ” 2,310,972ì£�입니ë‹�.

신고섵ӗµç� íˆ¬ìž ê²°ì •ì€ ì „í˜€ ì´ë£¨ì–´ì§€ì§€ 않았ë‹�ê³� 명시ë˜ì–´ 있으ë©�, 주ì‹ì€ ì—°ë°© 세금 ë‚©ë¶€ë¥� 위해서만 ì°¨ê°ë˜ì—ˆìŠµë‹ˆë‹�. ì´ë²ˆ ìˆ˜ì •ì€ 2024ë…� 3ì›� 12ì¼ì— 제출ë� ì›ë³¸ ì–‘ì‹ 4ì� â€œí–‰ì •ì  ì˜¤ë¥˜â€ë¥¼ ë°”ë¡œìž¡ì€ ê²ƒìž…ë‹ˆë‹¤.

  • 거래 성격: 비공ê°� 시장 세금 ì›ì²œì§•수 ì´ë²¤íŠ�.
  • ë‚´ë¶€ìž� ì§€ë¶„ì— ë¯¸ì¹˜ëŠ� ì˜í–¥: Kaoì� 보유 ì§€ë¶„ì´ 2% 미만으로 ê°ì†Œí–ˆìœ¼ë©�, 여전íž� ìƒë‹¹í•� ì†Œìœ ê¶Œì„ ìœ ì§€í•˜ê³  있습니다.
  • 시장ì—� 미치ëŠ� ì˜ë¯¸: ì˜ë¬´ì ì´ë©� ALHCì� ì „ë§ì—� 대í•� 신호가 아니므ë¡� ì¼ë°˜ì ìœ¼ë¡� 중립ì ìœ¼ë¡� 간주ë©ë‹ˆë‹�.

Alignment Healthcare (ALHC) � Formulaire 4 modifié (Formulaire 4/A)

Le PDG et administrateur John E. Kao a corrigé un formulaire 4 antérieur pour refléter le nombre exact d’actions retenues pour les obligations fiscales déclenchées par l’acquisition de unités d’actions restreintes basées sur le service (RSU). Le 08 mars 2024, 35 801 actions ordinaires ont été automatiquement retenues à un prix implicite de 5,39 $ par action sous le code de transaction « F » (retenue fiscale, non discrétionnaire). Après cet ajustement, la propriété directe de Kao s’élève à 2 310 972 actions.

Le dépôt précise explicitement qu�aucune décision d’investissement n’a été prise ; les actions ont été retirées uniquement pour satisfaire aux obligations fiscales fédérales. L’amendement corrige une « erreur administrative » dans le formulaire 4 original déposé le 12 mars 2024.

  • Nature de la transaction : Opération de retenue fiscale hors marché ouvert.
  • Impact sur la participation de l’initié : Réduction de moins de 2 % des avoirs de Kao ; il conserve une position de propriété importante.
  • Signification pour le marché : Généralement considérée comme neutre car obligatoire et ne reflète pas le sentiment sur les perspectives d’ALHC.

Alignment Healthcare (ALHC) � Geändertes Formular 4 (Formular 4/A)

CEO und Direktor John E. Kao korrigierte ein zuvor eingereichtes Formular 4, um die korrekte Anzahl der für Steuerverpflichtungen einbehaltenen Aktien aufgrund der Vesting von dienstbasierten Restricted Stock Units (RSUs) widerzuspiegeln. Am 08. März 2024 wurden 35.801 Stammaktien automatisch zu einem impliziten Preis von $5,39 pro Aktie gemäß Transaktionscode „F� (steuerliche Einbehaltung, nicht diskretionär) einbehalten. Nach der Anpassung beträgt Kaos direkte wirtschaftliche Beteiligung 2.310.972 Aktien.

Die Einreichung stellt ausdrücklich klar, dass keine Investitionsentscheidung getroffen wurde; die Aktien wurden ausschließlich zur Erfüllung der Bundessteuerverpflichtungen entnommen. Die Änderung korrigiert einen „administrativen Fehler� im ursprünglichen Formular 4, das am 12. März 2024 eingereicht wurde.

  • Art der Transaktion: Nicht am offenen Markt, steuerliche Einbehaltung.
  • Auswirkung auf Insider-Beteiligung: Weniger als 2 % Reduktion von Kaos Anteilen; er behält eine bedeutende Eigentumsposition.
  • Bedeutung für den Markt: Wird typischerweise als neutral angesehen, da es verpflichtend ist und keine Aussage über die Aussichten von ALHC trifft.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
KAO JOHN E

(Last) (First) (Middle)
1100 W. TOWN & COUNTRY RD., SUITE 1600

(Street)
ORANGE CA 92868

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Executive Officer
3. Date of Earliest Transaction (Month/Day/Year)
03/08/2024
4. If Amendment, Date of Original Filed (Month/Day/Year)
03/12/2024
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/08/2024 F 35,801(1) D $5.39 2,310,972 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based restricted stock units ("RSUs"). The withholding of these shares occurred automatically upon the vesting of the RSUs, and as such, no investment decision was made by the Reporting Person in connection with this transaction.
Remarks:
This Amendment is filed to correct the number of shares withheld for the payment of tax liabilities in connection with the vesting of service-based RSUs. The original Form 4 reflected an incorrect amount due to an administrative error.
/s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao 07/11/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

Why did ALHC CEO John E. Kao file an amended Form 4?

The amendment corrects the number of shares withheld for taxes on vested RSUs, fixing an earlier administrative error.

How many ALHC shares were withheld for taxes?

35,801 common shares were automatically withheld on 03-08-2024 under Transaction Code “F.�

Does the transaction indicate the CEO is selling stock?

No. Code “F� signifies shares withheld by the issuer to cover tax liabilities; it is not an open-market sale.

What is John E. Kao’s current ALHC ownership after the withholding?

He directly owns 2,310,972 common shares following the transaction.

Is this insider transaction likely to impact ALHC stock price?

Unlikely. Tax-withholding events are routine and generally viewed as neutral by investors.

When was the original Form 4 filed?

The original was filed on 12-Mar-2024; this amendment was submitted on 11-Jul-2025.
Alignment Healthcare, Inc.

NASDAQ:ALHC

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data

2.57B
144.41M
6.12%
92.15%
3.68%
Healthcare Plans
Hospital & Medical Service Plans
United States
ORANGE